Suministros de Nivolumab (DOE), Ipilimumab (DOE), Fedratinib (DOE), Luspatercept (DOE), Azacitidina (DOE) y Abatacept (DOE)
Deadline:N/A
Tender information
Araba/Álava
Type
Contract award
Procedure
Negotiated without a call for competition
Ref. number
2026/01511
Estimated value
€56,530,520.58
Duration
5 years
Suministros de Nivolumab (DOE), Ipilimumab (DOE), Fedratinib (DOE), Luspatercept (DOE), Azacitidina (DOE) y Abatacept (DOE)
1 - L1_NIVOLUMAB (DOE)
L1_NIVOLUMAB (DOE)
2 - L2_IPILIMUMAB (DOE)
L2_IPILIMUMAB (DOE)
3 - L3_FEDRATINIB (DOE)
L3_FEDRATINIB (DOE)
4 - L4_LUSPATERCEPT (DOE)
L4_LUSPATERCEPT (DOE)
5 - L5_AZACITIDINA (DOE)
L5_AZACITIDINA (DOE)
6 - L6_ABATACEPT (DOE)
L6_ABATACEPT (DOE)
Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Contract award
BRISTOL-MYERS SQUIBB, S.A.
AwardedBuyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Contract awarded
Important dates
4 Nov - Publication date
Unlock Full Access with Mercell Bidding Business Plus